Vetmab Biosciences, Inc.
Developing Life-Changing Therapeutics For Our Pets Monoclonal antibodies (mAbs) for modern veterinary practices Developing Life-Changing Therapeutics For Our Pets Monoclonal... Read More
Funding history
About Vetmab Biosciences, Inc.
How much funding has Vetmab Biosciences, Inc. raised?
Vetmab Biosciences, Inc. has raised $575K in total funding. The most recent round was Seed.
Where is Vetmab Biosciences, Inc. headquartered?
Vetmab Biosciences, Inc. is headquartered in San Diego, CA.
What does Vetmab Biosciences, Inc. do?
Developing Life-Changing Therapeutics For Our Pets Monoclonal antibodies (mAbs) for modern veterinary practices Developing Life-Changing Therapeutics For Our Pets Monoclonal... Read More
What problem does Vetmab Biosciences, Inc. solve?
Dogs and cats suffer from many of the same chronic diseases as humans, but monoclonal antibody therapies for them remain underdeveloped, leaving sub-par or no approved treatments for some conditions.
What's Vetmab Biosciences, Inc.'s solution?
Develops monoclonal antibody (mAb) therapeutics designed specifically for dogs and cats.
What makes Vetmab Biosciences, Inc. different?
Adapts human-validated drug targets specifically for dogs and cats using proprietary technology to reduce technical risk, built by a team that has previously developed similar therapies together.
What makes Vetmab Biosciences, Inc. notable?
Vetmab Biosciences was founded in 2022 in San Diego by Richard Chin, Denise Bevers, and Hangjun Zhan, and counts Yuhan, Ascendant Venture, Flybridge, XFactor Ventures, and CONNECT San Diego among its investors.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.